Agents Used in Antiretroviral Therapy

  • Authors: Philip Grant, MD (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 4/9/19 (What's New)

Summary

  • Currently only 1 FDA-approved CCR5 antagonist is available: maraviroc (Table 11)
    • Individual viral tropism must be determined when candidacy for a CCR5 antagonist is being considered
  • Maraviroc
    • Maraviroc, in combination with other antiretroviral agents, is indicated for adult patients infected with CCR5-tropic HIV only[FDA Maraviroc]

Action required